Ascentage Pharma Group International
HKEX:6855.HK
38.8 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 1,069.296 | 1,581.6 | 1,492.24 | 1,698.708 | 1,743.821 | 1,103.01 | 1,024.4 | 430.651 | 882.457 | 760.898 | 957.088 |
| Short Term Investments
| 6.557 | 0 | 11.905 | 0 | 4.145 | 428.704 | 3.026 | 216.989 | 2.599 | 2.567 | 14.399 |
| Cash and Short Term Investments
| 1,069.296 | 1,581.6 | 1,504.145 | 1,698.708 | 1,747.966 | 1,531.714 | 1,027.426 | 647.64 | 885.056 | 796.495 | 971.487 |
| Net Receivables
| 145.893 | 81.613 | 54.356 | 80.677 | 53.968 | 10.336 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 16.167 | 5.023 | 9.448 | 5.254 | 3.93 | -428.704 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 81.728 | 92.603 | 68.539 | 80.828 | 79.416 | 484.705 | 51.618 | 244.129 | 24.049 | 65.557 | 6.421 |
| Total Current Assets
| 1,344.178 | 1,760.839 | 1,636.488 | 1,865.467 | 1,885.28 | 1,598.051 | 1,079.044 | 674.78 | 909.105 | 829.022 | 990.219 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 957.232 | 633.056 | 648.722 | 968.462 | 844.368 | 616.636 | 477.001 | 258.656 | 142.287 | 92.293 | 33.992 |
| Goodwill
| 24.694 | 24.694 | 24.694 | 24.694 | 24.694 | 24.694 | 24.694 | 24.694 | 24.694 | 24.694 | 24.694 |
| Intangible Assets
| 85.446 | 80.107 | 84.304 | 90.834 | 60.411 | 63.771 | 66.405 | 69.983 | 72.192 | 73.826 | 108.528 |
| Goodwill and Intangible Assets
| 110.14 | 104.801 | 108.998 | 115.528 | 85.105 | 88.465 | 91.099 | 94.677 | 96.886 | 98.52 | 133.222 |
| Long Term Investments
| 18.949 | 18.657 | 18.531 | 21.097 | 27.845 | 29.856 | 31.774 | 39.328 | 32.191 | 34.832 | 45.119 |
| Tax Assets
| 59.842 | 50.747 | 54.294 | 46.613 | 51.648 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 10.052 | -50.747 | -54.294 | -46.613 | -51.648 | -734.957 | -599.874 | -392.661 | -271.364 | -225.645 | 26.824 |
| Total Non-Current Assets
| 1,156.215 | 756.514 | 776.251 | 1,105.087 | 957.318 | 734.957 | 599.874 | 392.661 | 271.364 | 225.645 | 239.157 |
| Total Assets
| 2,500.393 | 2,918.083 | 2,830.261 | 3,034.909 | 2,940.06 | 2,408.204 | 1,731.039 | 1,105.54 | 1,205.05 | 1,072.05 | 1,229.376 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 72.445 | 47.719 | 95.559 | 85.734 | 70.861 | 28.402 | 23.361 | 11.397 | 13.084 | 5.353 | 5.081 |
| Short Term Debt
| 616.404 | 405.305 | 518.383 | 311.948 | 49.451 | 33.613 | 50.561 | 68.466 | 92.194 | 107.16 | 37.587 |
| Tax Payables
| 8.389 | 0 | 7.179 | 0.248 | 3.279 | 5.311 | 5.984 | 0 | 1.6 | 1.046 | 1.004 |
| Deferred Revenue
| 0 | -405.305 | -518.383 | -311.948 | -49.451 | -33.613 | -50.561 | -68.466 | -92.194 | -107.16 | 0 |
| Other Current Liabilities
| 245.324 | 595.157 | 785.593 | 526.569 | 290.248 | 165.387 | 252.787 | 125.29 | 188.978 | 169.735 | 62.601 |
| Total Current Liabilities
| 934.173 | 642.876 | 881.152 | 612.303 | 361.109 | 193.789 | 276.148 | 136.687 | 202.062 | 175.088 | 105.269 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 1,179.191 | 1,258.946 | 1,265.2 | 1,241.133 | 1,026.592 | 622.536 | 473.055 | 212.862 | 9.211 | 2,426.13 | 4.457 |
| Deferred Revenue Non-Current
| 287.549 | 207.547 | 218.625 | 230.902 | 243.279 | 40.203 | 40.207 | 38.42 | 35.097 | 33.165 | 27.032 |
| Deferred Tax Liabilities Non-Current
| 10.549 | 11.35 | 12.151 | 12.951 | 13.753 | 14.554 | 15.355 | 16.156 | 16.957 | 17.758 | 18.559 |
| Other Non-Current Liabilities
| 18.299 | -218.897 | -230.776 | -243.853 | -257.032 | -54.757 | -55.562 | -54.576 | 51.248 | -50.923 | 2,085.645 |
| Total Non-Current Liabilities
| 1,495.588 | 1,258.946 | 1,265.2 | 1,241.133 | 1,026.592 | 622.536 | 473.055 | 212.862 | 112.513 | 2,426.13 | 2,135.693 |
| Total Liabilities
| 2,429.761 | 2,317.905 | 2,421.603 | 2,158.061 | 1,705.323 | 958.309 | 884.418 | 493.327 | 314.575 | 2,695.545 | 2,240.962 |
| Equity: | |||||||||||
| Preferred Stock
| 504.461 | 479.132 | 518.514 | 517.926 | 550.949 | 500.372 | 509.812 | 426.588 | 467.503 | 448.289 | 615.817 |
| Common Stock
| 0.197 | 0.196 | 0.18 | 0.179 | 0.178 | 0.172 | 0.154 | 0.142 | 0.142 | 0.063 | 0.063 |
| Retained Earnings
| -5,365.122 | -4,841.836 | -4,439.485 | -3,963.295 | -3,556.561 | -3,150.819 | -2,774.137 | -2,415.708 | -2,096.531 | -1,249.132 | -615.817 |
| Accumulated Other Comprehensive Income/Loss
| -504.461 | -479.132 | -518.514 | -517.926 | -550.949 | -500.372 | -509.812 | -426.588 | -467.503 | -448.289 | -14.757 |
| Other Total Stockholders Equity
| 5,425.342 | 5,431.526 | 4,847.963 | 4,839.964 | 4,791.12 | 4,600.542 | 3,620.604 | 3,027.779 | 2,986.864 | -374.426 | -996.892 |
| Total Shareholders Equity
| 60.417 | 589.886 | 408.658 | 876.848 | 1,234.737 | 1,449.895 | 846.621 | 612.213 | 890.475 | -1,623.495 | -1,011.586 |
| Total Equity
| 70.632 | 600.178 | 408.658 | 876.848 | 1,234.737 | 1,449.895 | 846.621 | 612.213 | 890.475 | -1,623.495 | -1,011.586 |
| Total Liabilities & Shareholders Equity
| 2,500.393 | 2,918.083 | 2,830.261 | 3,034.909 | 2,940.06 | 2,408.204 | 1,731.039 | 1,105.54 | 1,205.05 | 1,072.05 | 1,229.376 |